Market Context — Why This Technology, Why Now

The global shift towards sustainable agriculture is accelerating, driven by consumer demand for organic produce, stricter environmental regulations on chemical pesticides, and the escalating problem of pesticide-resistant pests. This technology aligns perfectly with ESG initiatives, offering a non-toxic, highly specific approach to pest management that protects biodiversity and supports long-term ecological balance, positioning companies to meet future market and regulatory demands.

Key Competitive Advantages
01

Significantly Reduces Environmental Impact: Acts only on germline cells, minimizing impact on non-target species and the environment, contributing to sustainable agriculture.

02

High Uniqueness and Robust Patent Rights: Only one prior art document exists, highlighting strong technical superiority. Robust rights were established after overcoming examiner objections.

03

High Versatility for Lepidopteran Insects: Targets specific genes, making it applicable to a wide variety of lepidopteran insect species for broad pest control applications.

Market Opportunity
Agriculture & Horticulture
$1.5B–$2.5B globally (AI est.)
Strong demand for reducing environmental impact from chemical pesticides and solving resistant pest issues is accelerating the shift towards biopesticides and Sterile Insect Technique (SIT).
Large-scale agricultural producers Horticulture supply companies Agrochemical manufacturers developing bio-alternatives
Forestry
$300M–$400M globally (AI est.)
Severe damage from forest pests necessitates broad-area, environmentally conscious pest control technologies.
Forestry management corporations Government forestry agencies Environmental conservation groups
Public Health
$600M–$700M globally (AI est.)
New, environmentally friendly control methods are sought for insect-borne diseases like dengue fever and malaria.
Public health organizations Mosquito control service providers Pharmaceutical companies researching vector control
IP Defensibility — Why Competitors Can't Replicate This
What This Patent Covers

This patent protects a method for producing sterile lepidopteran insects and a sterilization composition, specifically by suppressing nanosO and nanosP gene expression. The patent was granted after successfully addressing an examiner's rejection, indicating a robust and clearly defined scope of protection with 13 claims, making it less susceptible to invalidation.

Competitive White Space

This patent focuses on nanosO/P gene suppression in lepidopteran insects. White space exists in applying similar genetic sterilization techniques to other insect orders or developing novel gene targets for pest control beyond germline cell formation.

Economic Impact
~$1.5M/year estimated pesticide-related cost reduction per facility (est.)
estimated ROI · USD · AI analysis
ROI Calculation Logic

Assuming annual pesticide and application costs (including labor and environmental monitoring) are ~$13.5K/hectare (AI est.), a 10-20% reduction over 100 hectares could yield ~$135K/year (AI est.) in savings. Factoring in reduced costs from suppressing resistant pests and potential premium pricing from enhanced brand value, the total economic impact could reach ~$1.5M/year (AI est.).

Speed to Market
5× faster than in-house development
This technology's strength lies in its clearly established sterilization mechanism targeting specific genes (nanosO/P) in lepidopteran insects. Licensees can significantly shorten new R&D periods by leveraging this proven genetic target and basic expression suppression protocol. This allows for bypassing the basic research phase and rapidly moving to demonstration and optimization, potentially accelerating market entry by approximately 4 years.
Competitive Positioning

X: Environmental Impact Reduction
Y: Pest Control Efficiency

Business Models & Applications
🤝 Technology Licensing
License the technology and intellectual property to agricultural material manufacturers or biotechnology companies, generating royalty revenue.
🔬 Joint Development & Contract Research
Collaborate on developing sterilization protocols specific to target lepidopteran pests or conduct large-scale demonstration experiments to optimize the technology.
🏭 Production and Sale of Sterile Insects
Produce sterile lepidopteran insects using this technology and supply them directly to agricultural cooperatives, local governments, or large-scale farms.
Adjacent Application Opportunities
🌿 Organic Agriculture
Organic Certified Pest Control Solution
For organic farming where chemical pesticides are prohibited, this technology could provide a sterile insect-based control system, supporting stable harvests while meeting organic certification standards. It could reduce crop losses by an estimated 15-20% in affected areas.
🧬 Bioinformatics
Novel Biopesticide Development Platform
Applying the nanosO/P gene suppression principle, a research and development platform could be built to identify specific gene targets for other pest species or pathogens. This could accelerate the development of next-generation biopesticides and biological control agents, potentially reducing R&D cycles by 25%.
🌍 Environmental Consulting
Ecosystem-Preserving Pest Management Programs
Integrate this technology into comprehensive pest management programs for large-scale agricultural lands, forests, or urban areas, considering the entire ecosystem. This could offer consulting services from environmental assessment to implementation and operation, potentially reducing overall pest damage by 30%.
Integration Roadmap — Estimated 22-Month Deployment
Phase 1: Technology Evaluation and Protocol Establishment
Duration: 4 months
Re-evaluate basic data for this technology and assess applicability to the licensee's target lepidopteran species. Establish optimal gene expression suppression protocols and formulate an initial demonstration plan.
Phase 2: Demonstration and Optimization
Duration: 9 months
Conduct demonstration experiments in controlled environments to evaluate sterile insect production and impact on target pest populations. Collect data on sterilization efficiency and production costs, optimizing the technology for practical application.
Phase 3: Commercialization and Market Rollout
Duration: 9 months
Based on demonstration results, establish production lines and supply systems. Coordinate with regulatory authorities, develop and execute market introduction strategies, aiming for broad business expansion in agriculture and environmental sectors.
Technical Feasibility
This technology is based on a clear technical mechanism of specific gene expression suppression. Therefore, it is estimated that existing insect rearing facilities and research institutions or companies with genetic manipulation capabilities can adopt and implement it relatively easily, without requiring new large-scale capital investment. The patent abstract's mention of 'simple, stable, and efficient sterilization' suggests a low technical barrier to entry.
Success Scenario
Implementing this technology could enable licensees to establish a sustainable pest control system with low environmental impact for specific lepidopteran pests. This is estimated to reduce chemical pesticide use by up to 20%, contributing to compliance with stricter environmental regulations and improving corporate ESG ratings. Furthermore, it could offer a new solution to resistant pest issues, ensuring stable long-term crop production and potentially increasing annual revenue by 5-10%.
Patent Record
APPLICATION NO.
特願2022-162235
REGISTRATION NO.
7730163
FILING DATE
2022/10/07
GRANT DATE
2025/08/19
EXPIRATION DATE
2042/10/07
PATENT HOLDER
国立研究開発法人農業・食品産業技術総合研究機構
Examination History
2024年12月11日
早期審査に関する事情説明書
2024年12月11日
出願審査請求書
2025年01月07日
早期審査に関する通知書
2025年03月04日
拒絶理由通知書
2025年04月28日
意見書
2025年04月28日
手続補正書（自発・内容）
2025年07月08日
特許査定